Jennifer Taubert

Jennifer Taubert is Executive Vice President and Worldwide Chairman, Innovative Medicine at Johnson & Johnson, the world’s largest healthcare company. Jennifer is a leader in shaping the global strategy of transformational medical innovation for the Innovative Medicine sector, successfully delivering vital new medicines to prevent, treat and cure complex diseases including cancer; immune-related disorders; serious mental illness; cardiovascular disease; retinal disease and pulmonary hypertension. Under her leadership, J&J Innovative Medicine has become the second-largest pharmaceutical business globally, with more than $57 billion in worldwide revenue. The company has been named No. 1 in the Pharmaceuticals category on Fortune magazine’s “World’s Most Admired Companies” list for 10 consecutive years. Before joining Johnson & Johnson, Jennifer held positions of increasing responsibility at Merck and Allergan. Boards & Memberships: - Board of Directors of the Pharmaceutical Research and Manufacturers of America and Chair of the Federal Committee. - National Academy of Medicine’s Leadership Consortium - Advisory Board of the Leonard D. Schaeffer Center for Health Policy and Economics. - Board of Directors of McDonald’s Corporation. Education: Jennifer received a bachelor’s degree in Pharmacology from the University of California, Santa Barbara and a Master of Business Administration from the Anderson Graduate School of Management, University of California, Los Angeles.